e10vq
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 27, 2004

Commission file number 000-49602

SYNAPTICS INCORPORATED

(Exact name of Registrant as specified in its charter)
     
Delaware   77-0118518

 
 
 
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification No.)

2381 Bering Drive
San Jose, California 95131


(Address of principal executive offices) (Zip code)

(408) 434-0110


(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    No   o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x    No   o

Number of shares of Common Stock outstanding at May 4, 2004: 24,834,789

 


Table of Contents

SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2004

TABLE OF CONTENTS

                 
            Page
Part I.   Financial Information        
  Item 1.   Financial Statements (Unaudited):        
      Condensed Consolidated Balance Sheets- March 31, 2004 and June 30, 2003     3  
      Condensed Consolidated Statements of Operations- Three Months and Nine Months Ended March 31, 2004 and 2003     4  
      Condensed Consolidated Statements of Cash Flows- Nine Months Ended March 31, 2004 and 2003     5  
      Notes to Condensed Consolidated Financial Statements     6  
  Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations     11  
  Item 3.   Quantitative and Qualitative Disclosures About Market Risk     18  
  Item 4.   Controls and Procedures     18  
Part II.   Other Information        
    Item 6.Exhibits and Reports on Form 8-K     19  
Signatures         20  
 EX-31.1
 EX-31.2
 EX-32.1
 EX-32.2

 


Table of Contents

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)
(unaudited)

                 
    March 31,   June 30,
    2004
  2003
ASSETS
               
Current Assets:
               
Cash and cash equivalents
  $ 55,494     $ 41,697  
Short-term investments
    35,291       35,589  
Restricted cash
    240       240  
Accounts receivable, net of allowances of $130 and $160, respectively
    18,808       13,181  
Inventories
    5,477       6,428  
Prepaid expenses and other current assets
    2,779       2,637  
 
   
 
     
 
 
Total current assets
    118,089       99,772  
Property and equipment, net
    1,976       1,934  
Goodwill
    1,891       1,968  
Other assets
    937       834  
 
   
 
     
 
 
 
  $ 122,893     $ 104,508  
 
   
 
     
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
    8,300       6,893  
Accrued compensation
    3,632       2,808  
Accrued warranty
    891       1,002  
Income taxes payable
    4,788       1,661  
Other accrued liabilities
    2,638       3,362  
Capital leases and equipment financing obligations
    55       231  
 
   
 
     
 
 
Total current liabilities
    20,304       15,957  
Capital leases and equipment financing obligations, net of current portion
          28  
Note payable to a related party
    1,500       1,500  
Other liabilities
    843       759  
Stockholders’ equity:
               
Common stock; $0.001 par value; 60,000,000 shares authorized; 24,814,164 and 23,835,877 shares issued and outstanding, respectively
    25       24  
Additional paid-in capital
    83,111       78,761  
Deferred stock compensation
    (760 )     (1,184 )
Notes receivable from stockholders
          (20 )
Accumulated other comprehensive income
    14       100  
Retained earnings
    17,856       8,583  
 
   
 
     
 
 
Total stockholders’ equity
    100,246       86,264  
 
   
 
     
 
 
 
  $ 122,893     $ 104,508  
 
   
 
     
 
 

See notes to consolidated financial statements.

3


Table of Contents

SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)
(unaudited)

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Net revenue
  $ 34,284     $ 26,103     $ 98,129     $ 72,479  
Cost of revenue (1)
    19,726       15,385       57,286       41,745  
 
   
 
     
 
     
 
     
 
 
Gross margin
    14,558       10,718       40,843       30,734  
 
   
 
     
 
     
 
     
 
 
Operating expenses:
                               
Research and development (1)
    5,613       4,942       15,839       15,077  
Selling, general, and administrative (1)
    3,452       2,715       9,819       7,957  
Amortization of other acquired intangible assets
                      40  
Amortization of deferred stock compensation
    128       137       397       363  
Restructuring
                432        
 
   
 
     
 
     
 
     
 
 
Total operating expenses
    9,193       7,794       26,487       23,437  
 
   
 
     
 
     
 
     
 
 
Income from operations
    5,365       2,924       14,356       7,297  
Interest and other income, net
    246       259       701       815  
Interest expense
    (33 )     (35 )     (101 )     (121 )
 
   
 
     
 
     
 
     
 
 
Income before provision for income taxes
    5,578       3,148       14,956       7,991  
Provision for income taxes
    2,073       1,079       5,683       2,877  
 
   
 
     
 
     
 
     
 
 
Net income
  $ 3,505     $ 2,069     $ 9,273     $ 5,114  
 
   
 
     
 
     
 
     
 
 
Net income per share:
                               
Basic
  $ 0.14     $ 0.09     $ 0.38     $ 0.22  
 
   
 
     
 
     
 
     
 
 
Diluted
  $ 0.13     $ 0.08     $ 0.34     $ 0.21  
 
   
 
     
 
     
 
     
 
 
Shares used in computing net income per share:
                               
Basic
    24,671,358       23,537,666       24,266,653       23,407,637  
 
   
 
     
 
     
 
     
 
 
Diluted
    27,451,066       25,125,131       26,921,070       24,869,050  
 
   
 
     
 
     
 
     
 
 


(1)   Cost of revenue excludes $5,000, $7,000, $15,000, and $21,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. Research and development expense excludes $21,000, $38,000, $76,000, and $115,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. Selling, general, and administrative expenses exclude $102,000, $92,000, $306,000, and $227,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. These amounts have been aggregated and reflected as “Amortization of deferred stock compensation.”

See notes to consolidated financial statements.

4


Table of Contents

SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)
(unaudited)

                 
    Nine Months Ended
    March 31,
    2004
  2003
Cash flows from operating activities
               
Net income
  $ 9,273     $ 5,114  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation of property and equipment
    786       1,071  
Amortization of other acquired intangible assets
          40  
Amortization of deferred stock compensation
    397       363  
Fair value of options issued to consultants for services rendered
          17  
Changes in operating assets and liabilities:
               
Accounts receivable
    (5,627 )     (910 )
Inventories
    951       85  
Prepaid expenses and other current assets
    (142 )     (781 )
Other assets
    (103 )     10  
Accounts payable
    1,407       939  
Accrued compensation
    824       222  
Accrued warranty
    (111 )      
Income taxes payable
    3,127       404  
Other accrued liabilities
    (648 )     529  
Other liabilities
    84       57  
 
   
 
     
 
 
Net cash provided by operating activities
    10,218       7,160  
 
   
 
     
 
 
Cash flows from investing activities
               
Purchases of short-term investments
    (17,336 )     (18,144 )
Proceeds from sales and maturities of short-term investments
    17,548       3,569  
Purchase of property and equipment
    (828 )     (898 )
 
   
 
     
 
 
Net cash used in investing activities
    (616 )     (15,473 )
 
   
 
     
 
 
Cash flows from financing activities
               
Payments on capital leases and equipment financing obligations
    (204 )     (363 )
Proceeds from issuance of common stock upon exercise of options and stock purchase plan
    4,379       1,648  
Repayment of notes receivable from stockholders
    20       121  
 
   
 
     
 
 
Net cash provided by financing activities
    4,195       1,406  
 
   
 
     
 
 
Net increase (decrease) in cash and cash equivalents
    13,797       (6,907 )
Cash and cash equivalents at beginning of period
    41,697       45,491  
 
   
 
     
 
 
Cash and cash equivalents at end of period
  $ 55,494     $ 38,584  
 
   
 
     
 
 
Supplemental disclosures of cash flow information
               
Cash paid for interest
  $ 5     $ 22  
Cash paid for income taxes
    2,550       2,442  

See notes to consolidated financial statements

5


Table of Contents

SYNAPTICS INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. Basis of Presentation

     The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and generally accepted accounting principles. However, certain information or footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In our opinion, the statements include all adjustments, which are of a normal and recurring nature, necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended June 30, 2003.

     The consolidated financial statements include our financial statements and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

     The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

     On an on-going basis, we evaluate our estimates, including those related to revenue recognition, allowances for doubtful accounts, inventory, product warranties, and income taxes. These estimates are based on historical facts and various other assumptions we believe to be reasonable at the time the estimates are made.

     Our fiscal year ends on the last Saturday in June. For ease of presentation, the accompanying consolidated financial statements have been shown as ending on June 30 and calendar quarter ends for all annual, interim, and quarterly financial statement captions.

     We have elected to follow APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations in accounting for stock options. Had compensation expense for stock options been determined based on the fair value of the option at date of grant consistent with the provisions of Statement of Financial Accounting Standard No. 123, “Accounting for Stock-Based Compensation,” net income and earnings per share would have been reduced to the pro forma amounts indicated below (in thousands, except per share amounts):

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Net income — as reported
  $ 3,505     $ 2,069     $ 9,273     $ 5,114  
Add: Total stock-based employee compensation included in reported net income, net of related tax
    79       137       244       363  
Deduct: Total stock-based employee compensation determined under fair value based method for all awards, net of related tax
    (1,156 )     (778 )     (3,017 )     (2,018 )
 
   
 
     
 
     
 
     
 
 
Net income — pro forma
  $ 2,428     $ 1,428     $ 6,500     $ 3,459  
 
   
 
     
 
     
 
     
 
 
Net income per share — Basic:
                               
As reported
  $ 0.14     $ 0.09     $ 0.38     $ 0.22  
 
   
 
     
 
     
 
     
 
 
Pro forma
  $ 0.10     $ 0.06     $ 0.27     $ 0.15  
 
   
 
     
 
     
 
     
 
 
Net income per share — Diluted:
                               
As reported
  $ 0.13     $ 0.08     $ 0.34     $ 0.21  
 
   
 
     
 
     
 
     
 
 
Pro forma
  $ 0.09     $ 0.06     $ 0.24     $ 0.14  
 
   
 
     
 
     
 
     
 
 

     The fair value of each award granted was estimated at the date of grant using a Black-Scholes option-pricing model, assuming no expected dividends and the following weighted average assumptions:

6


Table of Contents

                                 
                    Employee Stock
    Stock Options
  Purchase Plan
    Three Months Ended   Three Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Expected volatility
    79.1 %     84.5 %     68.2 %     84.5 %
Expected life in years
    5       5       0.4       0.4  
Risk-free interest rate
    2.8 %     2.8 %     1.0 %     1.1 %
Weighted average fair value
  $ 10.38     $ 4.90     $ 2.65     $ 2.73  
                                 
                    Employee Stock
    Stock Options
  Purchase Plan
    Nine Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Expected volatility
    71.6 %     84.5 %     65.0 %     84.5 %
Expected life in years
    5       5       0.4       0.4  
Risk-free interest rate
    2.8 %     2.8 %     1.0 %     1.1 %
Weighted average fair value
  $ 8.00     $ 4.21     $ 2.57     $ 2.86  

2. Revenue Recognition

     We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery has occurred and title has transferred, the price is fixed and determinable, and collectibility is reasonably assured. We accrue for estimated sales returns and other allowances at the time we recognize revenue, which is typically upon shipment, based on historical experience. Contract revenue for research and development is recorded as earned based on the performance requirements of the contract. Non-refundable contract fees for which no further performance obligations exist, and for which there is no continuing involvement by us, are recognized on the earlier of when the payments are received or when collection is assured.

3. Net Income Per Share

     Basic net income per share amounts have been computed using the weighted average number of shares of common stock outstanding during each period. Diluted net income per share amounts also include the effect of potentially dilutive securities, including stock options, when dilutive.

     The following table presents the computation of basic and diluted net income per share (in thousands, except per share amounts):

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Numerator for basic and diluted net income per share:
                               
Net income
  $ 3,505     $ 2,069     $ 9,273     $ 5,114  
 
   
 
     
 
     
 
     
 
 
Denominator for basic net income per share:
                               
Weighted average common shares outsanding
    24,671       23,537       24,267       23,407  
 
   
 
     
 
     
 
     
 
 
Denominator for basic net income per share
    24,671       23,537       24,267       23,407  
 
   
 
     
 
     
 
     
 
 
Denominator for diluted net income per share:
                               
Shares used above, basic
    24,671       23,537       24,267       23,407  
Effect of dilutive stock options
    2,780       1,588       2,654       1,462  
 
   
 
     
 
     
 
     
 
 
Denominator for diluted net income per share
    27,451       25,125       26,921       24,869  
 
   
 
     
 
     
 
     
 
 
Net income per share:
                               
Basic
  $ 0.14     $ 0.09     $ 0.38     $ 0.22  
 
   
 
     
 
     
 
     
 
 
Diluted
  $ 0.13     $ 0.08     $ 0.34     $ 0.21  
 
   
 
     
 
     
 
     
 
 

7


Table of Contents

     Options to purchase 19,000, 1,415,923, 125,720, and 1,286,224 shares of common stock that were outstanding during the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively, were not included in the computation of diluted earnings per share for these periods because the options’ exercise prices were greater than the average market price of our common stock during these periods, and therefore, their effect would have been antidilutive.

4. Cash Equivalents and Short-term Investments

     Cash equivalents consist of highly liquid investments with original maturities of three months or less. Short-term investments consist of marketable securities and are classified as securities “available for sale” under Statement of Financial Accounting Standards No. 115, “Accounting for Certain Investments in Debt and Equity Securities”. Such securities are reported at fair value, with unrealized gains and losses, net of taxes, excluded from earnings and shown separately as a component of accumulated other comprehensive income within stockholders’ equity. Interest earned on marketable securities is included in interest income. Realized gains and losses on the sale of marketable securities are determined using the specific identification method.

5. Restructuring

     In late June 2003, we completed the acquisition of NSM Technology Limited (NSM), a Hong Kong company. In conjunction with the acquisition of NSM, duplicate operational positions were identified at our San Jose and Taiwan locations. During the three months ended September 30, 2003, we recorded $432,000 related to the elimination of those positions as restructuring charges. There were no restructuring charges for the three months ended March 31, 2004 and 2003 and the nine months ended March 31, 2003. The restructuring expenses consisted primarily of severance costs for the terminated employees who were notified in early July 2003.

6. Inventories

     Inventories are stated at the lower of cost (first-in, first-out method) or market (estimated net realizable value) and consisted of the following (in thousands):

                 
    March 31,   June 30,
    2004
  2003
Raw materials
  $ 5,205     $ 6,062  
Finished goods
    272       366  
 
   
 
     
 
 
 
  $ 5,477     $ 6,428  
 
   
 
     
 
 

     Write-downs to reduce the carrying value of obsolete, slow moving, and non-usable inventory to its net realizable value are charged to cost of revenue.

7. Goodwill

     The carrying amount of goodwill was as follows (in thousands):

                 
    March 31,   June 30,
    2004
  2003
NSM acquisition
  $ 1,125     $ 1,202  
ASL acquisition
    766       766  
 
   
 
     
 
 
 
  $ 1,891     $ 1,968  
 
   
 
     
 
 

8. Product Warranties and Indemnifications

     We generally warrant our products for a period of 12 to 37 months from the date of sale and estimate probable product warranty costs at the time revenue is recognized. Factors that affect our warranty liability include historical and anticipated rates of warranty claims, material usage, and service delivery costs. We assess the adequacy of our warranty obligations periodically and adjust the accrued warranty liability on the basis of our estimates.

8


Table of Contents

     Changes in our warranty liability for the nine-month periods ended March 31, 2004 and 2003 were as follows (in thousands):

                 
    Nine Months Ended
    March 31,
    2004
  2003
Beginning accrued warranty
  $ 1,002     $ 1,002  
Provision for product warranties
    384       37  
Cost of warranty claims
    (495 )     (37 )
 
   
 
     
 
 
Ending accrued warranty
  $ 891     $ 1,002  
 
   
 
     
 
 

     In connection with certain third-party agreements we have executed in the past, we are obligated to indemnify the third party in connection with any technology infringement by us. Maximum potential future payments cannot be estimated because these agreements do not have a maximum stated liability. However, historical costs related to these indemnification provisions have not been significant. We have not recorded any liability in our consolidated financial statements for such indemnification.

9. Income Taxes

     The income tax provision for the nine-month periods ended March 31, 2004 and 2003 reflects an effective income tax rate based on expected pre-tax income for the year partially offset by a research and development tax credit. The effective tax rates for the nine months ended March 31, 2004 and 2003 were approximately 38.0% and 36.0%, respectively, and represent a lower percentage than the combined federal and state statutory rate primarily due to the benefit of research and development tax credits and tax exempt interest income.

10. Segment, Customers, and Geographic Information

     We operate in one segment, the development, marketing, and sale of interactive user interface solutions for intelligent electronic devices and products, and currently generate our revenue primarily from companies in the personal computer (“PC”) market.

     The following is a summary of operations within geographic areas based on the customer location (in thousands):

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Revenue from sales to unaffiliated customers:
                               
China
  $ 20,629     $ 11,588     $ 52,457     $ 41,947  
Taiwan
    8,085       8,296       29,834       16,112  
Other
    5,570       6,219       15,838       14,420  
 
   
 
     
 
     
 
     
 
 
 
  $ 34,284     $ 26,103     $ 98,129     $ 72,479  
 
   
 
     
 
     
 
     
 
 

     Major customer data as a percentage of total revenue:

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Customer A
    31 %     12 %     24 %     11 %
Customer B
    *       *       10 %     *  

     Major customer data as a percentage of total accounts receivable:

                   
    March 31,   June 30,
    2004
  2003
Customer A
    35 %     26 %


*   Less than 10%

9


Table of Contents

11. Comprehensive Income

     Our comprehensive income consists of net income, plus the effect of unrealized gains and losses from short-term investments at fair value, which was not material for the nine months ended March 31, 2004 and 2003. Accordingly, comprehensive income closely approximates actual net income.

12. Recent Accounting Pronouncements

     In January 2003, the Financial Accounting Standards Board issued FASB Interpretation No. 46 (revised December 2003 by FIN 46R), “Consolidation of Variable Interest Entities,” which addresses how a business enterprise should evaluate whether it has a controlling financial interest in an entity through means other than voting rights and accordingly should consolidate the entity. FIN 46R replaces FASB Interpretation No. 46, Consolidation of Variable Interest Entities, which was issued in January 2003. We will be required to apply FIN 46R to variable interests in variable interest entities, or VIEs, created after December 31, 2003. For variable interests in VIEs created before January 1, 2004, the Interpretation will be applied beginning on January 1, 2005. For any VIEs that must be consolidated under FIN 46R that were created before January 1, 2004, the assets, liabilities, and non-controlling interests of the VIE initially would be measured at their carrying amounts with any difference between the net amount added to the balance sheet and any previously recognized interest being recognized as the cumulative effect of an accounting change. If determining the carrying amounts is not practicable, fair value at the date FIN 46R first applies may be used to measure the assets, liabilities, and non controlling interest of the VIE. The adoption of FIN 46R did not and will not have a material impact on our financial position, results of operations, or cash flows, as we do not have any VIEs.

     In December 2003, the SEC issued Staff Accounting Bulletin No. 104 (“SAB 104”), “Revenue Recognition.” SAB 104 supercedes SAB 101, “Revenue Recognition in Financial Statements.” The primary purpose of SAB 104 is to rescind accounting guidance contained in SAB 101 related to multiple element revenue arrangements, superceded as a result of the issuance of Emerging Issues Task Force (EITF) Issue No. 00-21 “Revenue Arrangements with Multiple Deliverables.” Additionally, SAB 104 rescinds the SEC’s Revenue Recognition in Financial Statements Frequently Asked Questions and Answers (“the FAQ”) issued with SAB 101 that had been codified in SEC Topic 13, Revenue Recognition. Selected portions of the FAQ have been incorporated into SAB 104. While wording of SAB 104 has changed to reflect the issuance of EITF 00-21, the revenue recognition principles of SAB 101 remain largely unchanged by the issuance of SAB 104. The adoption of SAB 104 did not have a material impact on our financial position, results of operations, or cash flows.

10


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements and Factors That May Affect Results

     You should read the following discussion and analysis in conjunction with our condensed consolidated financial statements and notes in Item 1 above and with our audited consolidated financial statements and notes for the year ended June 30, 2003, included in our Annual Report on Form 10-K.

     In addition to the historical information contained herein, this report contains forward-looking statements, including those related to market penetration and market share gains in the notebook, iAppliance, and other electronic device markets, revenue from the notebook, iAppliance, and other electronic device markets, growth rates of these markets, average selling prices, product mix, cost improvement programs, gross margins, customer relationships, research and development expenses, selling, general, and administrative expenses, and liquidity and anticipated cash requirements, that involve risks and uncertainties that could cause actual results to differ materially.

     We caution that these statements are qualified by various factors that may affect future results, including the following: changes in the market for our products and the success of our customers’ products, our success in moving products from the design phase into the manufacturing phase, warranty obligations related to product failures, the failure of key technologies to deliver commercially acceptable performance, our dependence on the notebook market, penetration into new markets, the absence of both long-term purchase and supply commitments, and our lengthy development and product acceptance cycles. This report should be read in conjunction with the Risk Factors discussed in our Annual Report on Form 10-K for the year ended June 30, 2003.

Overview

     We are a leading worldwide developer and supplier of custom-designed user interface solutions that enable people to interact more easily and intuitively with a wide variety of electronic devices. We began shipping our proprietary TouchPad in fiscal 1996 and are now the world’s leading supplier of interface solutions to the notebook computer market. Our interface solutions include our TouchPad, TouchStyk, and the combination of both a touchpad and pointing stick for dual pointing applications. We estimate that over half of all notebooks shipped during fiscal year 2003 contained our products. We believe our market share results from the combination of our customer focus, the strength of our intellectual property, and our engineering know-how, which allow us to design products that meet the demanding design specifications of original equipment manufacturers, or OEMs.

     Our manufacturing operations are based on a variable cost model in which we outsource all of our production requirements, eliminating the need for significant capital expenditures and allowing us to minimize our investment in inventories. This approach requires us to work closely with our manufacturing subcontractors to ensure adequate production capacity to meet our volume requirements. We provide our manufacturing subcontractors with six-month rolling forecasts and issue purchase orders based on our anticipated requirements for the next 90 days. We do not have any long-term supply contracts with any of our manufacturing subcontractors. Currently, we primarily use one third-party manufacturer to provide our proprietary capacitive-based application specific integrated circuits, or ASICs, and in certain cases we also rely on a single source or a limited number of suppliers to provide other key components of our products. Our cost of revenue includes all costs associated with the production of our products, including materials, manufacturing, and assembly costs paid to third-party manufacturers and related overhead costs associated with our manufacturing operations personnel. Additionally, all warranty costs and any inventory provisions or write-downs are charged to cost of revenue.

     Our gross margin generally reflects the combination of the added value we bring to our customers’ products in meeting their custom design requirements and our ongoing cost-improvement programs. In the future, we plan to introduce additional new products, which may initially negatively impact our gross margin, as was the case with the introduction of our initial dual pointing solutions in fiscal 2001.

     Our research and development expenses include costs related to product development, engineering, materials costs, patent expenses, and the costs incurred to design interface solutions for customers prior to the customers’ commitment to incorporate those solutions into their products. These expenses have generally increased, reflecting our continuing commitment to the technological and design innovation required to maintain a leadership position in our existing markets and to develop new technologies for new markets.

11


Table of Contents

     Selling, general, and administrative expenses include costs related to sales, marketing, and administrative personnel; internal sales and outside sales representatives’ commissions; market research and consulting; and other marketing and sales activities. Increased sales staffing and additional management personnel in anticipation of our continued growth in our existing markets and penetration into new markets have generally caused selling, general, and administrative expenses to increase.

     In connection with the grant of stock options to our employees and consultants, we have recorded deferred stock compensation of approximately $3.0 million, representing the difference between the deemed fair value of our common stock for financial reporting purposes and the exercise price of these options at the date of grant. Deferred stock compensation is presented as a reduction of stockholders’ equity and is amortized on a straight-line basis over the vesting period. Options granted are typically subject to a four-year vesting period. Restricted stock acquired through the exercise of unvested stock options is subject to our right to repurchase the unvested stock at the price paid, with the right to repurchase lapsing over the vesting period. We are amortizing the deferred stock compensation over the vesting periods of the applicable options and the repurchase periods for the restricted stock. As of March 31, 2004, there was $760,000 of deferred stock compensation remaining to be amortized in future periods.

Critical Accounting Policies and Estimates

     The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, allowance for doubtful accounts, inventory, product warranty, income taxes, intangible assets, and contingencies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements. Actual results may differ from these estimates under different assumptions or conditions.

Revenue Recognition

     We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery has occurred and title has transferred, the price is fixed and determinable, and collectibility is reasonably assured. We accrue for estimated sales returns and other allowances at the time we recognize revenue, which is typically upon shipment, based on historical experience. Contract revenue for research and development is recorded as earned based on the performance requirements of the contract. Non-refundable contract fees for which no further performance obligations exist, and for which there is no continuing involvement by us, are recognized on the earlier of when the payments are received or when collection is assured.

Allowance for Doubtful Accounts

     We maintain allowances for doubtful accounts for estimated losses resulting from the inability of customers to meet their financial obligations. On an ongoing basis, we evaluate the collectibility of accounts receivable based on a combination of factors. In circumstances where we are aware of a specific customer’s potential inability to meet its financial obligation, we record a specific reserve for bad debt against amounts due. In addition, we must make judgments and estimates of the collectibility of accounts receivable based on our historical bad debt experience, customers’ creditworthiness, current economic trends, recent changes in customer payment trends, and deterioration in the customers’ operating results or financial position. If circumstances change adversely, additional bad debt allowances may be required.

Inventory

     We state our inventories at the lower of cost or market. Our assessment of the ultimate realization of inventories is based on our projections of future demand and market conditions. Any sudden decline in demand, rapid product improvements, or technological changes, or any combination of these factors, can cause us to have excess or obsolete inventories. On an ongoing basis, we review for estimated obsolete or unmarketable inventories and write down our inventories to their net realizable value based upon our forecasts of future demand and market conditions. If actual market conditions are less favorable than our forecasts, additional inventory reserves may be required. Our estimates are influenced by the following considerations: sudden decline in demand due to an economic downturn,

12


Table of Contents

rapid product improvements and technological changes, and termination by our OEM customers of any product offerings incorporating our product solutions.

Product Warranties

     We provide for the estimated cost of product warranties at the time revenue is recognized. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers, our warranty obligation is affected by product failure rates, materials usage, and service delivery costs incurred in correcting a product failure. We exercise judgment in determining the estimates underlying our accrued warranty liability. The actual results with regard to warranty expenditures could have a material adverse effect on our operating results if the actual rate of unit failure is greater than what we used in estimating the accrued warranty liability.

Income Taxes

     We recognize federal, state, and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We also recognize federal, state, and foreign deferred tax liabilities or assets for our estimate of future tax effects attributable to temporary differences and carryfowards and record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized. If our assumptions and consequently our estimates change in the future, the valuation allowance we have established for our deferred tax assets may be changed, which could impact income tax expense. In addition, the calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of complex tax laws. Resolution of these uncertainties in a manner inconsistent with our expectations could have a material impact on our results of operations and financial condition. We account for income tax contingencies in accordance with Statement of Financial Accounting Standards No. 5, “Accounting for Contingencies”.

Results of Operations

Three months ended March 31, 2004 compared to three months ended March 31, 2003

                 
    Three Months Ended
    March 31,
    2004
  2003
Net revenue
    100.0 %     100.0 %
Cost of revenue
    57.5 %     58.9 %
 
   
 
     
 
 
Gross margin
    42.5 %     41.1 %
 
Operating expenses:
               
Research and development
    16.4 %     18.9 %
Selling, general, and administrative
    10.1 %     10.4 %
Amortization of deferred stock compensation
    0.4 %     0.6 %
 
   
 
     
 
 
Total operating expenses
    26.9 %     29.9 %
 
   
 
     
 
 
Income from operations
    15.6 %     11.2 %
Interest and other income, net
    0.7 %     1.0 %
Interest expense
    -0.1 %     -0.1 %
 
   
 
     
 
 
Income before provision for income taxes
    16.3 %     12.1 %
 
   
 
     
 
 
Provision for income taxes
    6.0 %     4.1 %
 
   
 
     
 
 
Net income
    10.2 %     8.0 %
 
   
 
     
 
 

     Net revenue was $34.3 million for the three months ended March 31, 2004 compared to $26.1 million for the three months ended March 31, 2003, an increase of 31%. The net increase in revenue was primarily attributable to a 46% increase in unit shipments from the March 2003 quarter to the March 2004 quarter. The impact of the increase in unit shipments was partially offset by a reduction in overall average selling prices, resulting from a change in product mix and general competitive pricing. Revenue from our dual pointing applications was approximately 30% of total revenue for the three months ended March 31, 2004 compared to 42% for the three months ended March 31, 2003. Our non-PC revenue grew to approximately 19% of total revenue for the three months ended March 31, 2004 from less than

13


Table of Contents

3% of total revenue for the three months ended March 31, 2003, primarily driven by increased demand for portable digital entertainment devices that utilize our capacitive interface solutions.

     Gross margin as a percentage of revenue was 42.5% for the three months ended March 31, 2004 compared to 41.1% for the three months ended March 31, 2003. The improvement in gross margin as a percentage of revenue primarily reflected a generally richer product mix of higher margin products, and our ongoing design and process improvement programs, partially offset by a lower average selling price resulting from general competitive pricing.

     Research and development expenses increased 13.6% to $5.6 million, or 16.4% of revenue, for the three months ended March 31, 2004 from $4.9 million, or 18.9% of revenue, for the three months ended March 31, 2003. The increase in research and development expenses reflected higher employee compensation costs from increased staffing, the impact of our annual performance review process and incentive pay programs, and to a lesser extent, higher project related expenses and patent costs, partially offset by lower outside consulting costs and depreciation charges.

     Selling, general, and administrative expenses increased 27.1% to $3.5 million, or 10.1% of revenue, for the three months ended March 31, 2004 from $2.7 million, or 10.4% of revenue, for the three months ended March 31, 2003. The increase in spending resulted mainly from higher compensation costs associated with our annual review process and incentive pay programs, increased staffing, project costs related to corporate compliance and planning activities, and our generally higher operating levels.

     The three months ended March 31, 2004 included amortization expense for deferred stock compensation of $128,000 compared to $137,000 for the three months ended March 31, 2003. We expect to record amortization expense for deferred stock compensation of approximately $120,000 in the remaining three months of fiscal 2004 and the balance of approximately $640,000 in future years.

     Net interest income was $213,000 for the three months ended March 31, 2004 compared to $224,000 for the three months ended March 31, 2003, resulting from generally lower interest rates. The impact of lower interest rates was partially offset by the benefit of higher average cash balances.

     The provision for income taxes for the three months ended March 31, 2004 was $2.1 million compared to $1.1 million for the three months ended March 31, 2003, reflecting the higher pre-tax profit levels. The income tax provision represents estimated federal and state taxes and the foreign taxes associated with our operations in the United Kingdom, Taiwan, and Japan for the three months ended March 31, 2004 and 2003, and the addition of Hong Kong for the three months ended March 31, 2004. The effective tax rates for the three month ended March 31, 2004 and March 31, 2003 were 37.2% and 34.3%, respectively, and represent a lower percentage than the combined federal and state statutory rate primarily due to the benefit of research and development tax credits and tax exempt interest income.

14


Table of Contents

Nine months ended March 31, 2004 compared to nine months ended March 31, 2003

                 
    Nine Months Ended
    March 31,
    2004
  2003
Net revenue
    100.0 %     100.0 %
Cost of revenue
    58.4 %     57.6 %
 
   
 
     
 
 
Gross margin
    41.6 %     42.4 %
Operating expenses:
               
Research and development
    16.1 %     20.8 %
Selling, general, and administrative
    10.0 %     11.0 %
Amortization of other acquired intangible assets
    0.0 %     0.0 %
Amortization of deferred stock compensation
    0.4 %     0.5 %
Restructuring
    0.5 %     0.0 %
 
   
 
     
 
 
Total operating expenses
    27.0 %     32.3 %
 
   
 
     
 
 
Income from operations
    14.6 %     10.1 %
Interest and other income, net
    0.7 %     1.1 %
Interest expense
    -0.1 %     -0.2 %
 
   
 
     
 
 
Income before provision for income taxes
    15.2 %     11.0 %
 
   
 
     
 
 
Provision for income taxes
    5.8 %     3.9 %
 
   
 
     
 
 
Net income
    9.4 %     7.1 %
 
   
 
     
 
 

     Net revenue was $98.1 million for the nine months ended March 31, 2004 compared to $72.5 million for the nine months ended March 31, 2003, an increase of 35.4%. The net increase in revenue was primarily attributable to a 59% increase in unit shipments, partially offset by a reduction in overall average selling price, resulting from a change in product mix and general competitive pricing. Revenue from our dual pointing applications was approximately 27% of our revenue for the nine months ended March 31, 2004 compared to 42% for the nine months ended March 31, 2003. The decrease in revenue from dual pointing applications reflected a shift toward single pointing solutions, driven by the combination of consumer and small business demand for low-priced notebook computers and the impact of competitive solutions in the dual pointing segment of the notebook market. Our non-PC revenue grew to approximately 15% of total revenue for the nine months ended March 31, 2004 from approximately 4% of total revenue for the nine months ended March 31, 2003, primarily driven by increased demand for portable digital entertainment devices that utilize our capacitive interface solutions.

     Gross margin as a percentage of revenue was 41.6% for the nine months ended March 31, 2004 compared to 42.4% for the nine months ended March 31, 2003. The reduction in gross margin as a percentage of revenue primarily reflected a shift in mix to lower margin products and a lower average selling price resulting from general competitive pricing, partially offset by lower manufacturing costs, driven by the combination of our ongoing design and process improvement programs and lower materials and assembly costs.

     Research and development expenses increased by 5.1% to $15.8 million, or 16.1% of revenue, for the nine months ended March 31, 2004 from $15.1 million, or 20.8% of revenue, for the nine months ended March 31, 2003. The increase in research and development expenses reflects higher employee compensation costs from increased staffing, our annual performance review process and incentive pay programs, project related expenses, and to a lesser extent, higher patent related expenses, partially offset by lower consulting costs and depreciation charges.

     Selling, general, and administrative expenses increased 23.4% to $9.8 million, or 10.0% of revenue, for the nine months ended March 31, 2004 from $8.0 million, or 11.0% of revenue, for the nine months ended March 31, 2003. The increase in spending resulted mainly from higher compensation costs associated with our annual review process and incentive pay programs, including higher commission expense on higher net revenue, additional expenses related to compliance with new SEC regulations, and our generally higher operating levels.

     The nine months ended March 31, 2004 included amortization expense for deferred stock compensation of $397,000 compared to $363,000 for the nine months ended March 31, 2003. We expect to record amortization expense for deferred stock compensation of approximately $120,000 in the remaining three months of fiscal 2004 and the balance of approximately $640,000 in future years.

15


Table of Contents

     Net interest income was $600,000 for the nine months ended March 31, 2004 compared to $694,000 for the nine months ended March 31, 2003, resulting from generally lower interest rates. The impact of lower interest rates was partially offset by the benefit of higher average cash balances.

     The provision for income taxes for the nine months ended March 31, 2004 was $5.7 million compared to $2.9 million for the nine months ended March 31, 2003, reflecting the higher pre-tax profit levels. The income tax provision represents estimated federal and state taxes and the foreign taxes associated with our operations in the United Kingdom, Taiwan, and Japan for the nine months ended March 31, 2004 and 2003, and the addition of Hong Kong for the nine months ended March 31, 2004. The effective tax rates for the nine months ended March 31, 2004 and March 31, 2003 were 38.0% and 36.0%, respectively, and represent a lower percentage than the combined federal and state statutory rate primarily due to the benefit of research and development tax credits and tax exempt interest income.

Liquidity and Capital Resources

     Our cash, cash equivalents, and short-term investments were $90.8 million as of March 31, 2004 compared to $77.3 million as of June 30, 2003, an increase of $13.5 million. In addition to cash, cash equivalents, and short-term investments, we held $240,000 of restricted cash as of March 31, 2004 and June 30, 2003, which represents amounts held in escrow for purchase price contingencies relating to our June 2003 acquisition of NSM Technology.

     During the nine months ended March 31, 2004, operating activities generated cash of approximately $10.2 million compared to $7.2 million of cash generated during the nine months ended March 31, 2003. For the nine months ended March 31, 2004, the net cash provided by operating activities was mainly attributable to net income of $9.3 million, plus depreciation and amortization of deferred stock compensation totaling $1.2 million, partially offset by higher working capital of $238,000. For the nine months ended March 31, 2003, net cash provided by operating activities was mainly attributable to net income of $5.1 million, plus depreciation and amortization of acquired intangible assets and deferred stock compensation totaling $1.5 million, and a decrease in working capital of $555,000.

     Our investing activities typically relate to purchases of government-backed securities and investment-grade fixed income instruments and purchases of property and equipment. Investing activities during the nine months ended March 31, 2004 used net cash of $616,000 compared to net cash used of $15.5 million during the nine months ended March 31, 2003. During the nine months ended March 31, 2004, net cash used in investing activities consisted of purchases of $17.3 million of short-term investments and $828,000 of capital equipment, offset by $17.5 million of proceeds from the sales and maturities of short-term investments. Cash used during the nine months ended March 31, 2003 consisted of purchases of $18.1 million of short-term investments and $898,000 of capital equipment, partially offset by cash provided by the proceeds from sales and maturities of short-term investments of $3.6 million.

     Net cash provided by financing activities for the nine months ended March 31, 2004 was $4.2 million compared to $1.4 million during the nine months ended March 31, 2003. For the nine months ended March 31, 2004 and 2003, financing activities primarily related to proceeds from common stock issued under our employee stock purchase plan and stock option plans, partially offset by payments made on capital lease and equipment financing obligations.

     Our principal sources of liquidity as of March 31, 2004 consisted of $90.8 million in cash, cash equivalents, and short-term investments and a $10.0 million working capital line of credit with Silicon Valley Bank. The Silicon Valley Bank revolving line of credit expires on November 28, 2004, has an interest rate equal to Silicon Valley Bank’s prime lending rate, and provides for a security interest in substantially all of our assets. We had not borrowed any amounts under the line of credit as of March 31, 2004. The long-term note payable of $1.5 million to National Semiconductor represents limited-recourse debt that is secured solely by a portion of our stockholdings in Foveon, Inc., in which National Semiconductor is also an investor. We do not anticipate making any payments under the limited-recourse loan with National Semiconductor, either prior to or at maturity, unless Foveon is participating in a liquidity event, such as an initial public offering of its equity securities or a merger, through which we would be able to receive amounts in excess of our $1.5 million long-term note payable plus accrued interest.

     We believe our existing cash balances will be sufficient to meet our cash requirements at least through the next 12 months. Our future capital requirements will depend on many factors, including our rate of revenue growth, the timing and extent of spending to support product development efforts, the expansion of sales and marketing activities, the timing of introductions of new products and enhancements to existing products, the costs to ensure access to adequate manufacturing capacity, the continuing market acceptance of our product solutions, and the amount and

16


Table of Contents

timing of our investments in, or acquisitions of, other technologies or companies. We cannot assure you that additional equity or debt financing will be available to us on acceptable terms or at all.

Contractual Obligations and Commercial Commitments

     The following table sets forth a summary of our material contractual obligations and commercial commitments as of March 31, 2004 (in thousands):

                                         
    Payments due by period
            Less than   1-3   3-5   More than
Contractual Obligations
  Total
  1 year
  Years
  Years
  5 Years
Note payable and interest
  $ 2,686     $     $     $ 2,686     $  
Building leases
    1,915       1,020       895              
Capital leases
    55       55                    
Inventory purchase obligations
    202       202                    
 
   
 
     
 
     
 
     
 
     
 
 
Total
  $ 4,858     $ 1,277     $ 895     $ 2,686     $  
 
   
 
     
 
     
 
     
 
     
 
 

Recent Accounting Pronouncements

     In January 2003, the Financial Accounting Standards Board issued FASB Interpretation No. 46 (revised December 2003 by FIN 46R), “Consolidation of Variable Interest Entities,” which addresses how a business enterprise should evaluate whether it has a controlling financial interest in an entity through means other than voting rights and accordingly should consolidate the entity. FIN 46R replaces FASB Interpretation No. 46, Consolidation of Variable Interest Entities, which was issued in January 2003. We will be required to apply FIN 46R to variable interests in variable interest entities, or VIEs, created after December 31, 2003. For variable interests in VIEs created before January 1, 2004, the Interpretation will be applied beginning on January 1, 2005. For any VIEs that must be consolidated under FIN 46R that were created before January 1, 2004, the assets, liabilities, and non-controlling interests of the VIE initially would be measured at their carrying amounts with any difference between the net amount added to the balance sheet and any previously recognized interest being recognized as the cumulative effect of an accounting change. If determining the carrying amounts is not practicable, fair value at the date FIN 46R first applies may be used to measure the assets, liabilities, and non controlling interest of the VIE. The adoption of FIN 46R did not and will not have a material impact on our financial position, results of operations, or cash flows, as we do not have any VIEs.

     In December 2003, the SEC issued Staff Accounting Bulletin No. 104 (“SAB 104”), “Revenue Recognition.” SAB 104 supercedes SAB 101, “Revenue Recognition in Financial Statements.” The primary purpose of SAB 104 is to rescind accounting guidance contained in SAB 101 related to multiple element revenue arrangements, superceded as a result of the issuance of Emerging Issues Task Force (EITF) Issue No. 00-21 “Revenue Arrangements with Multiple Deliverables.” Additionally, SAB 104 rescinds the SEC’s Revenue Recognition in Financial Statements Frequently Asked Questions and Answers (“the FAQ”) issued with SAB 101 that had been codified in SEC Topic 13, Revenue Recognition. Selected portions of the FAQ have been incorporated into SAB 104. While wording of SAB 104 has changed to reflect the issuance of EITF 00-21, the revenue recognition principles of SAB 101 remain largely unchanged by the issuance of SAB 104. The adoption of SAB 104 did not have a material impact on our financial position, results of operations, or cash flows.

17


Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     Market risk for our company has not changed significantly from the interest rate and foreign currency risks disclosed in Item 7A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2003.

ITEM 4. CONTROLS AND PROCEDURES

     As of the end of the period covered by this report, our Chief Executive Officer and Chief Financial Officer have reviewed and evaluated the effectiveness of our disclosure controls and procedures, which included inquiries made to certain other of our employees. Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have each concluded that our disclosure controls and procedures are effective and sufficient to ensure that we record, process, summarize, and report information required to be disclosed by us in our periodic reports filed under the Securities Exchange Act within the time periods specified by the Securities and Exchange Commission’s rules and forms.

     During the fiscal quarter covered by this report, there have not been any changes in our internal control over financial reporting that has materially affected, or is reasonable likely to materially affect, our internal control over financial reporting.

18


Table of Contents

PART II — OTHER INFORMATION

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

(a)    Exhibits:

             
    31.1     Certification of President and Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended
 
           
    31.2     Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended
 
           
    32.1     Certification of President and Chief Executive Officer, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
           
    32.2     Certification of Chief Financial Officer, pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(b)     Reports on Form 8-K:

     Report on Form 8-K dated January 22, 2004 furnishing Item 12 Results of Operations and Financial Condition disclosure.

19


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    SYNAPTICS INCORPORATED
(Registrant)
 
       
Date: May 6, 2004
  By:

Name:
Title:
  /s/ Francis F. Lee
Francis F. Lee
President and Chief Executive Officer
 
       
  By:

Name:
Title:
  /s/ Russell J. Knittel
Russell J. Knittel
Senior Vice President and Chief Financial Officer

20

exv31w1
 

EXHIBIT 31.1

CERTIFICATION

     I, Francis F. Lee, certify that:

     1. I have reviewed this quarterly report on Form 10-Q of Synaptics Incorporated;

     2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

     4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

     5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

     
Date: May 6, 2004
   
 
   
  /s/ Francis F. Lee
Francis F. Lee
President and Chief Executive Officer

exv31w2
 

EXHIBIT 31.2

CERTIFICATION

     I, Russell J. Knittel, certify that:

     1. I have reviewed this quarterly report on Form 10-Q of Synaptics Incorporated;

     2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

     3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

     4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

     b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

     c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

     5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

     
Date: May 6, 2004
   
 
   
  /s/ Russell J. Knittel
Russell J. Knittel
Senior Vice President, Chief Financial
Officer, Chief Administrative Officer,
Secretary, and Treasurer

exv32w1
 

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report on Form 10-Q of Synaptics Incorporated (the “Company”) for the quarterly period ended March 27, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Francis F. Lee, President, Chief Executive Officer, and Director of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
 
(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
     
/s/ Francis F. Lee
Francis F. Lee
President, Chief Executive Officer, and Director
May 6, 2004
   

exv32w2
 

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report on Form 10-Q of Synaptics Incorporated (the “Company”) for the quarterly period ended March 27, 2004 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Russell J. Knittel, Senior Vice President, Chief Financial Officer, Chief Administrative Officer, Secretary, and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
 
(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
     
/s/ Russell J. Knittel
Russell J. Knittel
Senior Vice President, Chief Financial Officer,
Chief Administrative Officer, Secretary, and Treasurer
May 6, 2004
   

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This website contains forward-looking statements that are subject to the safe harbors created under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business, and can be identified by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements may include words such as "expect," "anticipate," "intend," "believe," "estimate," "plan," "target," "strategy," "continue," "may," "will," "should," variations of such words, or other words and terms of similar meaning. All forward-looking statements reflect our best judgment and are based on several factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control. Such factors include, but are not limited to, the risks as identified in the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Business" sections of our Annual Report on Form 10-K for our most recent fiscal year, and other risks as identified from time to time in our Securities and Exchange Commission reports. Forward-looking statements are based on information available to us on the date hereof, and we do not have, and expressly disclaim, any obligation to publicly release any updates or any changes in our expectations, or any change in events, conditions, or circumstances on which any forward-looking statement is based. Our actual results and the timing of certain events could differ materially from the forward-looking statements. These forward-looking statements do not reflect the potential impact of any mergers, acquisitions, or other business combinations that had not been completed as of the date of this filing.